This report provides a detailed strategic analysis of AstraZeneca, a leading multinational pharmaceutical and biotechnology company. It begins with an introduction to strategic management and its importance, followed by an in-depth evaluation of the UK and global pharmaceutical industry. The analysis employs various frameworks, including SWOT, PESTLE, and industry lifecycle analysis, to critically assess AstraZeneca's position. The report examines AstraZeneca's strengths, weaknesses, opportunities, and threats, along with the political, economic, social, technological, legal, and environmental factors impacting the company. Furthermore, the report explores the competitive environment using Porter's Five Forces and strategic group analysis to understand the competitive dynamics. The conclusion summarizes the key findings and insights derived from the analysis, highlighting AstraZeneca's strategic position and its ability to navigate the complexities of the pharmaceutical industry. The report is a comprehensive study of AstraZeneca's strategic management and sustainability.
![[object Object]](/_next/static/media/star-bottom.7253800d.svg)
